Australian Clinical Labs (ASX: ACL)
A$2.79
(1.1%)
A$0.03
Price as of July 14, 2025, 2:00 a.m. ET
Australian Clinical Labs Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Australian Clinical Labs Company Info
Australian Clinical Labs Ltd. engages in the provision of pathology services. It operates through the Pathology segment. The Pathology segment includes pathology/clinical laboratory services provided in Australia. The company was founded in 2015 and is headquartered in Clayton, Australia.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.